Knight C - Search Results

1

Clinical and cost-effectiveness of electroconvulsive therapy for depressive illness, schizophrenia, catatonia and mania: systematic reviews and economic modelling studies.

Greenhalgh J, Knight C, Hind D, Beverley C, Walters S. Greenhalgh J, et al. Among authors: knight c. Health Technol Assess. 2005 Mar;9(9):1-156, iii-iv. doi: 10.3310/hta9090. Health Technol Assess. 2005. PMID: 15774232 Free article. Review.

2

Rituximab (MabThera) for aggressive non-Hodgkin's lymphoma: systematic review and economic evaluation.

Knight C, Hind D, Brewer N, Abbott V. Knight C, et al. Health Technol Assess. 2004 Sep;8(37):iii, ix-xi, 1-82. doi: 10.3310/hta8370. Health Technol Assess. 2004. PMID: 15361313 Free article. Review.

3

Cost effectiveness of representatives of three classes of antidepressants used in major depression in the UK.

Lenox-Smith A, Conway P, Knight C. Lenox-Smith A, et al. Among authors: knight c. Pharmacoeconomics. 2004;22(5):311-9. doi: 10.2165/00019053-200422050-00005. Pharmacoeconomics. 2004. PMID: 15061681

4

Cost effectiveness of venlafaxine compared with generic fluoxetine or generic amitriptyline in major depressive disorder in the UK.

Lenox-Smith A, Greenstreet L, Burslem K, Knight C. Lenox-Smith A, et al. Among authors: knight c. Clin Drug Investig. 2009;29(3):173-84. doi: 10.2165/00044011-200929030-00004. Clin Drug Investig. 2009. PMID: 19243210

5

Economic Modeling Considerations for Rare Diseases.

Pearson I, Rothwell B, Olaye A, Knight C. Pearson I, et al. Among authors: knight c. Value Health. 2018 May;21(5):515-524. doi: 10.1016/j.jval.2018.02.008. Epub 2018 Apr 17. Value Health. 2018. PMID: 29753347 Free article. Review.

6

Economic modelling of different treatment strategies for haemophilia A with high-responding inhibitors.

Knight C, Paisley S, Wight J, Jones ML. Knight C, et al. Haemophilia. 2003 Jul;9(4):521-40. doi: 10.1046/j.1365-2516.2003.00783.x. Haemophilia. 2003. PMID: 12828681 Review.

7

A systematic review of the cost-effectiveness of rFVIIa and APCC in the treatment of minor/moderate bleeding episodes for haemophilia patients with inhibitors.

Knight C, Danø AM, Kennedy-Martin T. Knight C, et al. Haemophilia. 2009 Mar;15(2):405-19. doi: 10.1111/j.1365-2516.2008.01969.x. Epub 2009 Feb 1. Haemophilia. 2009. PMID: 19187191 Review.

8

Cost-effectiveness of treatment with etanercept for psoriasis in Sweden.

Knight C, Mauskopf J, Ekelund M, Singh A, Yang S, Boggs R. Knight C, et al. Eur J Health Econ. 2012 Apr;13(2):145-56. doi: 10.1007/s10198-010-0293-8. Epub 2011 Mar 6. Eur J Health Econ. 2012. PMID: 21380772

9

The cost-effectiveness, of pegcetacoplan compared with ravulizumab for the treatment of paroxysmal nocturnal hemoglobinuria, in a UK setting.

Hakimi Z, Wilson K, McAughey E, Pochopien M, Wojciechowski P, Toumi M, Knight C, Sarda SP, Patel N, Wiseman C, de Castro NP, Nazir J, Kelly RJ. Hakimi Z, et al. Among authors: knight c. J Comp Eff Res. 2022 Sep;11(13):969-985. doi: 10.2217/cer-2022-0076. Epub 2022 Jul 7. J Comp Eff Res. 2022. PMID: 35796199 Free article.

10

Tramadol and the risk of fracture in an elderly female population: a cost utility assessment with comparison to transdermal buprenorphine.

Hirst A, Knight C, Hirst M, Dunlop W, Akehurst R. Hirst A, et al. Among authors: knight c. Eur J Health Econ. 2016 Mar;17(2):217-27. doi: 10.1007/s10198-015-0673-1. Epub 2015 Apr 11. Eur J Health Econ. 2016. PMID: 25861916 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,371 results

Search Page

Filters